Calibrate: Changing the way the world treats weight
Obesity is an urgent, growing problem facing Americans, underscored by an astonishing lack of access: 70% of the U.S. population is overweight or obese, and this number is trending upward, yet there are only 4,000 obesity board-certified doctors. Billions of dollars of enterprise value have been created by companies tackling the problem from different angles — lifestyle solutions to bariatric surgery to pharmacological treatment — and consumers and health plans together spend hundreds of billions of dollars addressing the problem. However, Americans are gaining 1–2 pounds per person, annually, and the number of Americans suffering from obesity has increased by more than 30% since 2013.
Conventional, universal weight loss options don’t work, and it’s the reason why we invested in Calibrate, the company re-imagining the category by treating obesity as what it’s proven to be, a metabolic condition deeply rooted in biological and environmental factors.
Based on science-backed methods, Calibrate gives consumers control over their whole metabolic system and their weight. They offer a year-long entirely virtual metabolic reset that combines metabolic medication prescribed through telemedicine and 1:1 coaching to target four proven pillars of metabolic health: food, sleep, exercise, and emotional health. This helps unlock long term access to the proven-effective combination of behavior therapy and metabolic medications that the current healthcare system has been unable to provide.
Powered by doctors and scaled with technology, the Calibrate model efficiently and holistically addresses a nuanced care pathway in order to drive better health outcomes at scale.
Led by a consumer health leader Isabelle Kenyon and designed in collaboration with the nation’s top weight and metabolic health researchers, along with pre-eminent experts in nutrition, health policy, and digital health, the Calibrate solution is a paramount example of healthcare meeting modern consumer needs in a category requiring change.
We invested late last year, and since then, the ‘why’ has never been more relevant. COVID-19 has brought obesity front-and-center with its identification as a leading risk factor in poor outcomes; and more recently, we have been reminded of the racial and social disparities further limiting access to care, mobilizing our country to action.
It’s never been more critical to take our health into our own hands, and we cannot wait to see the team scale Calibrate to increase access to better care for the millions of Americans affected by the obesity epidemic.
To learn more about Calibrate please go to www.joincalibrate.com
